Distal Radius Buckle Fracture RCT

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Completed
CT.gov ID
NCT04032873
Collaborator
(none)
129
1
2
28.3
4.6

Study Details

Study Description

Brief Summary

This study evaluates the influence of cost information on decision-making for immobilization for treatment of distal radial buckle fractures. Half of the participants will receive cost information from an orthopaedic surgeon prior to making their decision for treatment, while the other half will receive cost information from another member of the study team after they had made their decision treatment.

Condition or Disease Intervention/Treatment Phase
  • Other: Monetary Cost of Immobilization Treatments
  • Other: Physician
  • Other: Study Team
  • Other: Before Initial Treatment Decision
  • Other: After Initial Treatment Decision
N/A

Detailed Description

Research has shown equipoise in treatment outcomes after casting and splinting for pediatric buckle fractures. Despite the similarly favorable treatment outcomes associated with both casting and splinting these fractures, there is wide disparities in cost between the two types of immobilization. However, cost information is not routinely presented to families during the discussion of immobilization types.

The primary objective of this study is to determine if cost information influences family decision-making about immobilization type after pediatric buckle fractures. A secondary objective is to determine if the timing of and person disseminating the cost information changes the influence it has on families' decision-making.

Study Design

Study Type:
Interventional
Actual Enrollment :
129 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Influence of Cost Information on Cast vs. Splint Decision-Making After Pediatric Buckle Fractures: A Randomized Controlled Trial
Actual Study Start Date :
May 31, 2017
Actual Primary Completion Date :
Oct 9, 2019
Actual Study Completion Date :
Oct 9, 2019

Arms and Interventions

Arm Intervention/Treatment
Other: Provider Cost

The subject will be given information about the cost of casting and splinting for treatment of the buckle fracture by the orthopaedic surgeon before the decision for immobilization has been made.

Other: Monetary Cost of Immobilization Treatments
Information regarding the monetary cost of casting and splinting patient's buckle fracture to be presented to adult subject/payer.
Other Names:
  • Cost Information
  • Other: Physician
    The monetary cost information is relayed by the patient's physician

    Other: Before Initial Treatment Decision
    Monetary cost information is relayed during the initial consult, before the treatment decision is made.
    Other Names:
  • Initial Consult
  • Other: Research Team Cost

    The subject will be given information about the cost of casting and splinting for treatment of the buckle fracture by a member of the study team after the decision for immobilization has been made.

    Other: Monetary Cost of Immobilization Treatments
    Information regarding the monetary cost of casting and splinting patient's buckle fracture to be presented to adult subject/payer.
    Other Names:
  • Cost Information
  • Other: Study Team
    The monetary cost information is relayed by a member of the study team

    Other: After Initial Treatment Decision
    Monetary cost information is relayed after the initial consult with the treating physician, after the treatment decision is made.
    Other Names:
  • Post-Consult
  • Outcome Measures

    Primary Outcome Measures

    1. Monetary Cost of Immobilization's Influence on Treatment Decisions [1 to 5 minutes]

      The outcome measure will evaluate whether monetary cost influenced payers' decisions to choose one immobilization treatment over the other (splinting vs. casting).

    Secondary Outcome Measures

    1. Timing/Person Effect on Decision-Making [1 to 5 minutes]

      A secondary objective is to determine if the timing of and person disseminating the cost information changes the influence it has on families' decision-making

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Years to 14 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Males or females ages 4 to 14 years with a buckle fracture for which they will be treated with a cast or a splint.

    • Parental/guardian permission (informed consent) and, if appropriate, child assent.

    • Parent of a child ages 4 to 14 years with a buckle fracture that requires treatment with either a cast or a splint.

    • Parental/guardian permission (informed consent).

    Exclusion Criteria:
    • Non-English speaking subjects.

    • Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104

    Sponsors and Collaborators

    • Children's Hospital of Philadelphia

    Investigators

    • Principal Investigator: John Todd R Lawrence, MD, PhD, Children's Hospital of Philadelphia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Children's Hospital of Philadelphia
    ClinicalTrials.gov Identifier:
    NCT04032873
    Other Study ID Numbers:
    • 17-013965
    First Posted:
    Jul 25, 2019
    Last Update Posted:
    Feb 3, 2021
    Last Verified:
    Feb 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Children's Hospital of Philadelphia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 3, 2021